A Gene-Editing Therapy Cut Cholesterol Levels by Half
A groundbreaking gene-editing therapy using Crispr has shown promising results in reducing cholesterol levels in a small group of patients. The treatment, developed by Crispr Therapeutics, targets a gene...
Read more
